Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
Alexandre R. de Mello Schier,
Natalia P. de Oliveira Ribeiro,
Danielle S. Coutinho,
Jose A. Crippa,
Antonio W. Zuardi,
Antonio E. Nardi,
Adriana C. Silva.
Anxiety and depression are pathologies that affect human beings in many aspects of life, including social life,
productivity and health. Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis sativa with great
psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound. The aim of this study is to
review studies of animal models using CBD as an anxiolytic-like and antidepressant-like compound. Studies involving
animal models, performing a variety of experiments on the above-mentioned disorders, such as the forced swimming test
(FST), elevated plus maze (EPM) and Vogel conflict test (VCT), suggest that CBD exhibited an anti-anxiety and antidepressant
effects in animal models discussed. Experiments with CBD demonstrated non-activation of neuroreceptors
CB1 and CB2. Most of the studies demonstrated a good interaction between CBD and the 5-HT1A neuro-receptor.
Keywords: Anxiety, anxiolytic-like, cannabis sativa, cannabidiol, CBD, major depression.
Rights & PermissionsPrintExport